{"id":"NCT00856544","sponsor":"Pfizer","briefTitle":"A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications","officialTitle":"Phase 3, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of 2 Doses Of CP 690,550 In Patients With Active Rheumatoid Arthritis On Background DMARDS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05","primaryCompletion":"2011-01","completion":"2011-01","firstPosted":"2009-03-05","resultsPosted":"2013-01-10","lastUpdate":"2013-01-10"},"enrollment":795,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Arthritis, Rheumatoid"],"interventions":[{"type":"DRUG","name":"CP-690,550","otherNames":[]},{"type":"DRUG","name":"CP-690,550","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Active 5 mg","type":"EXPERIMENTAL"},{"label":"Active 10 mg","type":"EXPERIMENTAL"},{"label":"Placebo Sequence 1","type":"PLACEBO_COMPARATOR"},{"label":"Placebo Sequence 2","type":"PLACEBO_COMPARATOR"}],"summary":"This Phase 3 study is intended to provide evidence that CP-690,550 dosed 5 mg BID and 10 mg BID is safe and effective when used in combination with a variety of traditional disease modifying antirheumatic drugs in adult patients with rheumatoid arthritis. It is intended to confirm the benefits of CP-690,550 in improving signs and symptoms and physical function that were observed in the Phase 2 rheumatoid arthritis studies.","primaryOutcome":{"measure":"Percentage of Participants Achieving American College of Rheumatology 20% (ACR20) Response at Month 6","timeFrame":"Month 6","effectByArm":[{"arm":"CP-690,550 5 mg","deltaMin":52.73,"sd":null},{"arm":"CP-690,550 10 mg","deltaMin":58.25,"sd":null},{"arm":"Placebo","deltaMin":31.21,"sd":null}],"pValues":[{"comp":"OG001 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":133,"countries":["United States","Australia","Chile","China","Colombia","Croatia","Denmark","Finland","Germany","Greece","Malaysia","Mexico","Poland","Russia","Slovakia","Spain","Sweden","Thailand","United Kingdom","Venezuela"]},"refs":{"pmids":["39192350","38958913","37925660","37919780","37453736","36931693","36814062","36601090","36600185","36526796","35577477","35382883","34921355","34870800","33127856","33059710","32816215","30425195","30177460","29949132","29794874","28143815","27565000","26275429","25047021","24026258"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3921046&StudyName=A%20Study%20Comparing%202%20Doses%20Of%20CP-690%2C550%20Vs.%20Placebo%20For%20The%20Treatment%20Of%20Rheumatoid%20Arthritis%20In%20Patients%20On%20Other%20Background%20Arthri"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":315},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Headache","Diarrhoea","Bronchitis"]}}